MFI:NSD-mF International Limited Ordinary Shares (USD)

COMMON STOCK | Other |

Last Closing

USD 0.92

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.06M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-29 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap
WOOF Pet Acquisition LLC

-0.41 (-10.85%)

USD 7.56B
JSM Navient Corporation SR NT 6% 1..

+0.09 (+0.48%)

USD 5.23B
BHFAL Brighthouse Financial Inc

+0.23 (+1.05%)

USD 4.50B
RGC Regencell Bioscience Holdings ..

-0.15 (-4.46%)

USD 3.60B
OB Outbrain Inc

-0.15 (-3.01%)

USD 1.71B
RILYG B. Riley Financial Inc. 5.00% ..

+0.04 (+0.22%)

USD 0.54B
RILYZ B. Riley Financial Inc. 5.25% ..

+0.07 (+0.47%)

USD 0.54B
NEWTZ Newtek Business Services Corp...

-0.06 (-0.25%)

USD 0.45B
NEWTI NewtekOne Inc. 8.00% Fixed Rat..

+0.02 (+0.06%)

USD 0.43B
GAINN Gladstone Investment Corporati..

+0.08 (+0.33%)

USD 0.39B

ETFs Containing MFI

XST:CA iShares S&P/TSX Capped Co.. 1.66 % 0.61 %

N/A

CAD 0.21B

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain -96.51% 3% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -96.51% 2% F 2% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -1.91% 52% F 40% F
Dividend Return -1.91% 40% F 36% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.41% 71% C- 84% B
Risk Adjusted Return -14.26% 38% F 33% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.